Company: MDXG
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001376339-25-000048
Chunk: 3

Company: MIMEDX GROUP, INC.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 3
---
 10-K for the fiscal year ended December 31, 2024 (the “ 2024 Annual Report ”) are being first sent or given to our shareholders on or about April 30, 2025. The Company, on behalf of the Board, is soliciting your proxy to vote your shares at the 2025 Annual Meeting in accordance with your instructions. The Notice of Annual Meeting of Shareholders, this Proxy Statement, the 2024 Annual Report, and our form of proxy card are available at www.proxyvote.com.

Our principal executive offices are located at 1775 West Oak Commons Court, NE, Marietta, Georgia, 30062.

#### INFORMATION ABOUT THE ANNUAL MEETING

#### 1.

#### What is a proxy?
A proxy is your legal designation of another person to vote the shares of MiMedx you own on your behalf.

#### 2.

#### Who is soliciting my proxy?
The Board is soliciting your proxy to vote your shares on the matters before the Annual Meeting on your behalf. The Board has designated William F. Hulse IV and Kendall Lioon (the “ Named Proxies ”) to vote all shares for which the Company has been appointed to act as proxy at the Annual Meeting. The Named Proxies will vote any properly executed proxy, if received in time and not revoked, at the Annual Meeting in accordance with your directions. The Named Proxies will vote any signed proxy that fails to specify a choice on any proposal to be acted upon at the Annual Meeting in accordance with the Board’s voting recommendations (as described below), and, in the Named Proxies’ discretion, FOR or AGAINST such other business as may properly come before the Annual Meeting or any adjournment or postponement thereof.

The following table summarizes the Board’s recommendations with respect to the items of business to be considered at the Annual Meeting:

| Item |     | Description                                                                    |     | Board Recommendation   |
| 1    |     | Election of nine directors                                                     |     | FOR the Board nominees |
| 2    |     | Advisory Vote to Approve Executive Compensation                                |     | FOR                    |
| 3    |     | Ratification of Registered Public Accounting Firm                              |     | FOR                    |
| 4    |     | Approval of the amendment of the Company’s 2016 Equity and Cash Incentive Plan |     | FOR                    |
| 5    |     | Advisory Vote to Approve Frequency of Advisory Vote on Executive Compensation  |     |